Suzanna Shermon

Dr. Suzanna Shermon


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in Chronic Illness
Verified
Journal Article
Closed access
PDF file
SSSuzanna Shermon
Suzanna Shermon
MGMatthew Goldfinger
Matthew Goldfinger
AMAlexander Morris
Alexander Morris
BHBrian Harper
Brian Harper
ALAdena Leder
Adena Leder
SSSuzanna Shermon
Suzanna Shermon
To investigate how common modifiable exposures, including dietary factors, select toxicants, and anti-inflammatory medications, may affect Parkinson’s disease. Using surveys, a case-control study was conducted at a medical center, comparing Parkinson’s disease patients (N = 149) and healthy controls (N = 105). Subjects reported exposure to red meats, vegetables, alcohol, tobacco, anti-inflammatory medications, and pesticides. The relationship between exposures and Parkinson’s disease diagnosis was analyzed by logistic regression to generate odds ratio and 95% confidence interval. Consuming red meat “sometimes” or “always” was positively associated with Parkinson’s disease as compared to eating red meats “rarely” or “never”; (odds ratio = 2.15, 95% confidence interval = 1.06, 4.39; p = 0.03) and (odds ratio = 4.47, 95% confidence interval = 1.67, 11.94; p = 0.003), respectively. Exposure to pesticides showed a positive association with Parkinson’s disease (odds ratio = 2.84, 95% confidence interval = 1.34, 6.00; p = 0.007). “Always” use of aspirin was inversely associated with Parkinson’s disease (odds ratio = 0.32, 95% confidence interval = 0.14, 0.70; p = 0.004). “Ever” having used anti-histamines was inversely associated with Parkinson’s disease (odds ratio = 0.37, 95% confidence interval = 0.17, 0.81; p = 0.01). Our study suggests that there are modifiable external factors that are associated with Parkinson’s disease. The present study can thus assist clinicians, policy makers, and people living with Parkinson’s disease in improving the experience and management of Parkinson’s disease.

30 June 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SSSuzanna Shermon
Suzanna Shermon
KFKimberly Michelle Fazio
Kimberly Michelle Fazio
RSRichard Shim
Richard Shim
AAAlaa Abd-Elsayed
Alaa Abd-Elsayed
CKChong Kim
Chong Kim
Objective: The objective of this study was to evaluate discrepancies in prescription trends for analgesic medications in complex regional pain syndrome (CRPS) patients based on recommendations in the literature. Design: We conducted a retrospective case–control study. Subjects: A total of 2510 CRPS patients and 2510 demographic-matched controls participated in this study. Methods: The SlicerDicer feature in Epic was used to find patients diagnosed with CRPS I or II between January 2010 and November 2022. An equal number of age-, gender-, and race-matched controls without a CRPS diagnosis were retracted from Epic. General and CRPS-associated prescription frequencies for the following classes were retrieved for both cases and controls: benzodiazepines, bisphosphonates, calcitonin, capsaicin, neuropathic pain medications, NSAIDs, opioids, and steroids. Results: A total of 740 (29%) CRPS patients and 425 (17%) controls were prescribed benzodiazepines (95% CI 0.1–0.15), 154 (6.1%) CRPS patients and 52 (2.1%) controls were prescribed capsaicin (95% CI 0.03–0.05), 1837 (73%) CRPS patients and 927 (37%) controls were prescribed neuropathic pain medications (95% CI 0.05–0.34), 1769 (70%) CRPS patients and 1217 (48%) controls were prescribed opioids (95% CI 0.19–0.25), 1095 (44%) CRPS patients and 1217 (48%) controls were prescribed steroids (95% CI 0.08–0.14), and 1638 (65%) CRPS patients and 1765 (70%) controls were prescribed NSAIDs (95% CI −0.08–0.02), p < 0.001 for all classes. With CRPS-associated prescriptions, (95% CI 0.05–0.16, p < 0.001) more CRPS patients were prescribed opioids (N = 398, 59%) than controls (N = 327, 49%). Conclusions: CRPS is difficult to treat with significant variance in suggested treatment modalities. Based on the results of our study, there is a divergence between some published recommendations and actual practice.

12 August 2022 in Current Physical Medicine and Rehabilitation Reports
Verified
Journal Article
Closed access
PDF file
JWJames Wilson
James Wilson
ABAmber Brochetti
Amber Brochetti
SSSuzanna Shermon
Suzanna Shermon
ETElizabeth Twist
Elizabeth Twist

8 January 2024 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
SSSuzanna Shermon
Suzanna Shermon
CKChong Kim
Chong Kim
Objective: Cervical spine surgery may be needed in those with refractory pain or neurologic deficits to improve outcomes in patients with cervical spine disease. However, consensus varies in the literature on the effect of surgery on opioid use. The objectives of this study were to analyze prescription rates of multiple controlled substances before and after cervical spine surgery and distinguish factors that may have contributed to opioid use after surgery. Design: This is a retrospective cohort study analyzing prescription trends of various controlled substances in 632 patients who underwent cervical spine surgery from 2019 to 2021. Results: Opioids have the largest rise in prescriptions at 3- and 6-mo time points after cervical spine surgery. A significant association (P < 0.001) was found between opioid use 1 yr before and 1 yr after cervical spine surgery. Exposure to opioids before surgery (odds ratio = 2.77, 95% confidence interval = 1.43–5.51, P = 0.003) and higher morphine milligram equivalent dose (odds ratio = 1.02, 95% confidence interval =1.01–1.04, P = 0.012) were found to be associated with opioid use after surgery. Significantly more females were prescribed controlled substances (P = 0002). Conclusions: Higher morphine milligram equivalent dose and opioid exposure before surgery are important factors in predicting postsurgical opioid use.